Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis

Janeva, Slavica; Zhang, Chenyang; Kovács, Anikó; Z. Parris, Toshima; A. Crozier, Jennifer; M. Pezzi, Christopher; Linderholm, Barbro; A. Audisio, Riccardo; Olofsson Bagge, Roger

doi:10.1016/s2666-7568(20)30018-0

Public

Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis

Published in The Lancet Healthy Longevity • Nov 30, 2020

Authors:

Slavica Janeva

Chenyang Zhang

Anikó Kovács

Abstract

BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer associated with poor survival, in which adjuvant systemic treatments are limited to chemotherapy. Due to competing mortality risks and comorbidities, older patients with TNBC are often undertreated with adjuvant ...

Subject

Medicine

Breast cancer

Oncology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!